The Lipid-Lowering Agents market in Croatia has been experiencing steady growth in recent years.
Customer preferences: Croatian consumers are increasingly concerned about their cholesterol levels and are seeking out lipid-lowering agents to manage their health. This trend is in line with the global increase in cardiovascular disease and the growing awareness of the importance of preventative measures.
Trends in the market: The market for lipid-lowering agents in Croatia is dominated by statins, which are the most commonly prescribed type of medication for managing cholesterol levels. However, there has been a shift towards more personalized medicine, with patients increasingly seeking out alternative medications such as PCSK9 inhibitors. This trend is in line with the global move towards precision medicine and a more personalized approach to healthcare.
Local special circumstances: The Croatian healthcare system is publicly funded, which means that the government plays a significant role in determining which medications are available to patients. This can create challenges for pharmaceutical companies looking to introduce new products to the market. Additionally, the country's aging population is driving demand for lipid-lowering agents, which is likely to continue in the coming years.
Underlying macroeconomic factors: Croatia's economy has been growing steadily in recent years, which has led to an increase in disposable income and healthcare spending. This is likely to have a positive impact on the lipid-lowering agents market as consumers have more money to spend on healthcare products. Additionally, the country's accession to the European Union has led to increased regulatory harmonization, which has made it easier for pharmaceutical companies to introduce new products to the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
